₹ 62.26 Cr
2.44%
S&P BSE Healthcare TRI
INF397L01LG2
5000.0
500.0
Karan Doshi
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
LIC MF Healthcare Fund-Regular Plan-Growth | 45.81 | 9.67 | 19.52 |
S&P BSE Healthcare TRI | 52.5 | 14.07 | 21.99 |
Equity
Debt
Others
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.19 |
Zydus Lifesciences Ltd. | 7.0 |
JB Chemicals & Pharmaceuticals Ltd. | 6.44 |
Piramal Pharma Ltd. | 6.38 |
Cipla Ltd. | 6.1 |
Divi's Laboratories Ltd. | 5.34 |
Torrent Pharmaceuticals Ltd. | 5.26 |
Dr. Reddy's Laboratories Ltd. | 5.09 |
Glenmark Pharmaceuticals Ltd. | 4.74 |
Ipca Laboratories Ltd. | 4.61 |
Sector | Holdings (%) |
---|---|
Healthcare | 94.7 |
Others | 3.56 |
Chemicals | 1.74 |
Scheme Name | 5Y (%) |
---|---|
LIC MF Healthcare Fund Reg Gr | 19.52 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |